These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9595752)

  • 1. [Restenosis after coronary balloon angioplasty: the clinical problem].
    da Luz PL; Solimene MC
    Rev Assoc Med Bras (1992); 1997; 43(4):357-66. PubMed ID: 9595752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Restenosis after PTCA].
    Heidland UE; Michel CJ; Heintzen MP; Strauer BE
    Dtsch Med Wochenschr; 1998 Jul; 123(27):840-6. PubMed ID: 9685844
    [No Abstract]   [Full Text] [Related]  

  • 3. Instent restenosis: balloon angioplasty, rotablation or laser therapy.
    Sharma SK; Reich D; Kini A
    Indian Heart J; 1998 Oct; 50 Suppl 1():109-19. PubMed ID: 9824916
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet".
    Hermans WR; Rensing BJ; Strauss BH; Serruys PW
    Am Heart J; 1991 Jul; 122(1 Pt 1):171-87. PubMed ID: 2063736
    [No Abstract]   [Full Text] [Related]  

  • 5. Contemporary clinical trials of restenosis.
    Paranandi SN; Topol EJ
    J Invasive Cardiol; 1994 May; 6(4):109-24. PubMed ID: 10147167
    [No Abstract]   [Full Text] [Related]  

  • 6. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).
    Herrman JP; Hermans WR; Vos J; Serruys PW
    Drugs; 1993 Jul; 46(1):18-52. PubMed ID: 7691506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis after successful percutaneous transluminal coronary angioplasty.
    Klein LW; Rosenblum J
    Prog Cardiovasc Dis; 1990; 32(5):365-82. PubMed ID: 2179996
    [No Abstract]   [Full Text] [Related]  

  • 9. Abciximab to prevent vessel closure after angioplasty.
    Med Lett Drugs Ther; 1995 Jun; 37(950):52-3. PubMed ID: 7760769
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic effects of calcium channel blockers on restenosis.
    Thaulow E
    J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S12-6. PubMed ID: 10071258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical approaches to prevention of restenosis after coronary angioplasty.
    Blackshear JL; O'Callaghan WG; Califf RM
    J Am Coll Cardiol; 1987 Apr; 9(4):834-48. PubMed ID: 2951423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dealing with in-stent restenosis.
    Gershlick AH; Baron J
    Heart; 1998 Apr; 79(4):319-23. PubMed ID: 9616335
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials.
    Franklin SM; Faxon DP
    Coron Artery Dis; 1993 Mar; 4(3):232-42. PubMed ID: 8269217
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventing coronary restenosis and complications.
    Holmes DR
    N Engl J Med; 1997 Jun; 336(24):1748-9. PubMed ID: 9180094
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of intravascular stents as delivery devices to prevent restenosis.
    Pearce BJ; McKinsey JF
    Vasc Endovascular Surg; 2003; 37(4):231-7; discussion 237. PubMed ID: 12894364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.